$SION
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Healthcare
Sector
Biotechnology
Industry
Michael Cloonan
CEO
41
Employees
$37.32
Current Price
$1.84B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $347,018.88 | 10,250 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 4 | 6 | $13,106,750.55 | 322,156 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 4 | 8 | $16,078,770.16 | 388,868 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Fitzpatrick Jennifer Chief Legal Officer | Sale | 10,250 | $33.86 | $347,018.88 | View Details |
| Feb 3, 2026 | Thompson Peter A. Director | Sale | 29,063 | $44.58 | $1,295,628.54 | View Details |
| Feb 2, 2026 | Thompson Peter A. Director | Sale | 1,890 | $44.57 | $84,237.30 | View Details |
| Feb 2, 2026 | ORBIMED ADVISORS LLC Director | Sale | 1,890 | $44.57 | $84,237.30 | View Details |
| Feb 3, 2026 | ORBIMED ADVISORS LLC Director | Sale | 29,063 | $44.58 | $1,295,628.54 | View Details |
| Jan 22, 2026 | TPG GP A, LLC 10% Owner | Sale | 250,000 | $40.00 | $10,000,000.00 | View Details |
| Dec 24, 2025 | ORBIMED ADVISORS LLC Director | Sale | 33,356 | $44.55 | $1,486,009.80 | View Details |
| Dec 24, 2025 | Thompson Peter A. Director | Sale | 33,356 | $44.55 | $1,486,009.80 | View Details |
128 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.61
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: